© 2020 MJH Life Sciences and Urology Times. All rights reserved.
June 30, 2016
Four-year data on the prostatic urethral lift (UroLift) and data on a new water-jet ablation treatment were among BPH/LUTS highlights from this year’s meeting.
September 01, 2012
Men with previously treated castration-resistant prostate cancer (CRPC) lived almost 5 months longer when they received the androgen receptor signaling inhibitor enzalutamide.
Repeat surgery occurs two to three times as often after newer minimally invasive interventions for BPH compared with transurethral resection of the prostate.
A robot-assisted laparoscopic radical prostatectomy costs 40% more than a retropubic radical prostatectomy, according to a review of hospital data from one state.